← Back to Clinical Trials
Recruiting NCT07474610

NCT07474610 The Relationship Between Transversus Abdominis Muscle Architecture and Upper Extremity Function in Patients With Chronic Low Back Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07474610
Status Recruiting
Phase
Sponsor Ilayda Dilan Isik
Condition Low Back Pain
Study Type OBSERVATIONAL
Enrollment 90 participants
Start Date 2026-04-01
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 45 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 90 participants in total. It began in 2026-04-01 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Core stability is the ability to control the position and movement of the trunk for optimal production, transfer, and control of forces in the upper and lower extremities during functional activities. Studies have shown that TrA activation is delayed in individuals with low back pain. The relationship between core stability and the lower extremity has been frequently studied in the literature, and according to Kibler's 'Kinetic Chain' theory, loss of proximal stability is known to lead to dysfunction in distal segments; however, the relationship between the upper extremity and core stability is still unclear. The aim of our study is to investigate the upper extremity reach capacity and scapular stability of individuals with low back pain in relation to TrA involvement and to compare them with healthy individuals without low back pain.

Eligibility Criteria

Inclusion Criteria: * Being between 18-45 years of age. * Having a normal Body Mass Index (BMI) (18.5 - 29.9 kg/m²). * For the painful group, having pain for a minimum of 3 months and a minimum of 3/10 pain at rest or during activity. • Not having received medical treatment for back or shoulder pain in the last 12 months for healthy control examinations. Exclusion Criteria: * Having neurological diseases. * Having a diagnosed pathology and/or severe pain in the upper extremity. * Being a professional athlete. * Being pregnant. * Having advanced structural spinal deformities (scoliosis, kyphosis, etc.). * Having undergone abdominal surgery (Cesarean section is not included). * Having undergone spinal and/or lumbar surgery.

Contact & Investigator

Central Contact

İlayda Dilan Işık, MsC

✉ ilayda_dilan06@hotmail.com

📞 +905305239711

Frequently Asked Questions

Who can join the NCT07474610 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07474610 currently recruiting?

Yes, NCT07474610 is actively recruiting participants. Contact the research team at ilayda_dilan06@hotmail.com for enrollment information.

Where is the NCT07474610 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT07474610 clinical trial?

NCT07474610 is sponsored by Ilayda Dilan Isik. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology